Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M10,532Revenue $M13,372Net Margin (%)10.5Altman Z-Score1.2
Enterprise Value $M9,946EPS $1.1Operating Margin %16.5Piotroski F-Score7
P/E(ttm)25.2Beneish M-Score-2.8Pre-tax Margin (%)14.1Higher ROA y-yY
Price/Book0.710-y EBITDA Growth Rate %--Quick Ratio2.8Cash flow > EarningsY
Price/Sales2.55-y EBITDA Growth Rate %--Current Ratio3.2Lower Leverage y-yN
Price/Free Cash Flow13.2y-y EBITDA Growth Rate %96.2ROA % (ttm)3.5Higher Current Ratio y-yY
Dividend Yield %1.3PEG--ROE % (ttm)7.6Less Shares Outstanding y-yY
Payout Ratio %33.0Shares Outstanding M388ROIC % (ttm)8.9Gross Margin Increase y-yN

Gurus Latest Trades with MKGAY

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

MKGAY is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!

MKGAY: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about MKGAY:

    News about MKGAY:

    Articles On GuruFocus.com
    No related article found.

    More From Other Websites
    Merck Accelerator goes global with launch in Africa Jan 28 2016
    Merck Announces New Biopharma Heads for North America and China Jan 27 2016
    Merck and BrandWatch Technologies Form Long-Term Partnership Jan 21 2016
    Merck launches Vivera in Latin America Jan 20 2016
    Merck Appoints New Executive Board Members Jan 19 2016
    Merck Announces Favorable English Court Ruling on Name Use Jan 15 2016
    Merck and Biocartis to Collaborate on New Liquid Biopsy Technology for RAS Biomarker Testing Jan 07 2016
    Merck, Pfizer and Syndax Announce Collaboration to Evaluate Combination of Avelumab and Entinostat... Jan 04 2016
    Updated Digital Version of Periodic Table of the Elements Jan 04 2016
    Sigma-Aldrich Corporation -- Moody's withdraws all ratings of Sigma-Aldrich Dec 23 2015
    Merck and Pfizer Advance Clinical Development Program with Two Additional Phase III Trials of... Dec 22 2015
    Ronastar® Lapis Jewel – For Sparkling Deep Blue Cosmetics Dec 21 2015
    Merck Acquires Ormet Circuits Dec 14 2015
    Merck Confident for 2016 Dec 10 2015
    Merck and Pfizer Initiate Two Phase III Studies of Investigational Immunotherapy Avelumab in... Dec 09 2015
    European stocks dip on ECB doubts, US stocks rise Dec 01 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)